Compounds > 4-amino-1,8-naphthalimide
Page last updated: 2024-10-21

4-amino-1,8-naphthalimide and Leucocythaemia

4-amino-1,8-naphthalimide has been researched along with Leucocythaemia in 1 studies

4-amino-1,8-naphthalimide: inhibits ADP-ribosylation; sometimes abreviated as 4-AN;

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pogrebniak, A1
Schemainda, I1
Pelka-Fleischer, R1
Nüssler, V1
Hasmann, M1

Other Studies

1 other study available for 4-amino-1,8-naphthalimide and Leucocythaemia

ArticleYear
Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    European journal of medical research, 2003, Oct-22, Volume: 8, Issue:10

    Topics: 1-Naphthylamine; Adenosine Triphosphate; Alkylating Agents; Apoptosis; Benzamides; Cell Death; Cell

2003